4.7 Article

Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization

Delphine Planas et al.

Summary: The Omicron variant of SARS-CoV-2, identified in November 2021, has spread rapidly worldwide and shows resistance to most therapeutic monoclonal antibodies and vaccine-elicited antibodies. However, it can be neutralized by antibodies generated by a booster vaccine dose.

NATURE (2022)

Article Biochemistry & Molecular Biology

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies

Meng Yuan et al.

Summary: Since the outbreak of COVID-19 pandemic, researchers from diverse biomedical and biological disciplines have collaborated to study the novel pandemic virus SARS-CoV-2. The focus has been on the antibody response to SARS-CoV-2, crucial for vaccine and therapeutic development. Most of the neutralizing antibodies for SARS-CoV-2 target the spike protein receptor binding domain (RBD).

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2021)

Article Cell Biology

Rational development of a human antibody cocktail that deploys multiple functions to confer Pan-SARS-CoVs protection

Hangping Yao et al.

Summary: This study developed a therapeutic antibody cocktail against SARS-CoV-2 by exploiting antibody cooperativity, consisting of two antibodies that achieved synergistic neutralization through S1 shielding and conformational locking, blocking receptor attachment and viral membrane fusion to combat viral mutation escape. Additionally, a hypothetical third antibody partner was identified for further reinforcement as pan-SARS-CoVs therapeutics.

CELL RESEARCH (2021)

Letter Infectious Diseases

Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UK

Julian W. Tang et al.

JOURNAL OF INFECTION (2021)

Article Multidisciplinary Sciences

Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections

Chao Zhang et al.

Summary: The study identifies and characterizes two mouse-derived monoclonal antibodies targeting distinct epitopes on the SARS-CoV-2 spike protein, which can form a noncompeting antibody cocktail. A humanized version of the cocktail exhibits prophylactic and therapeutic antiviral effects in vitro, and shows the potential for treating SARS-CoV-2 infections.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein

Cheolmin Kim et al.

Summary: A human monoclonal antibody called CT-P59 has been shown to effectively neutralize SARS-CoV-2 and demonstrate significant therapeutic effects in animal models, making it a promising candidate for COVID-19 treatment.

NATURE COMMUNICATIONS (2021)

Article Microbiology

A Neutralization Assay Based on Pseudo-Typed Lentivirus with SARS CoV-2 Spike Protein in ACE2-Expressing CRFK Cells

Yalcin Pisil et al.

Summary: This study improved the existing neutralization assay system for evaluating SARS-CoV-2 inhibitors, showing higher sensitivity in assessing neutralizing antibodies. The method was successfully applied to quantify convalescent antisera and monoclonal anti-spike antibodies, demonstrating its potential in discovering new antiviral drugs.

PATHOGENS (2021)

Article Multidisciplinary Sciences

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Delphine Planas et al.

Summary: The SARS-CoV-2 B.1.617 Delta variant, first identified in India in 2020, has become dominant in some regions and is spreading to many countries. This variant shows resistance to certain monoclonal antibodies and antibodies in convalescent sera, as well as reduced neutralization by some COVID-19 vaccines. Administration of two doses of the vaccine is needed for a neutralizing response against the Delta variant.

NATURE (2021)

Article Multidisciplinary Sciences

A human monoclonal antibody blocking SARS-CoV-2 infection

Chunyan Wang et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2

Rui Shi et al.

NATURE (2020)

Article Multidisciplinary Sciences

Human neutralizing antibodies elicited by SARS-CoV-2 infection

Bin Ju et al.

NATURE (2020)

Article Multidisciplinary Sciences

Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Identification of an anti-SARS-CoV-2 receptor-binding domain-directed human monoclonal antibody from a naive semisynthetic library

Hilal Ahmad Parray et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Immunology

A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection

Wafaa B. Alsoussi et al.

JOURNAL OF IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Convergent antibody responses to SARS-CoV-2 in convalescent individuals

Davide F. Robbiani et al.

NATURE (2020)

Article Multidisciplinary Sciences

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

Lihong Liu et al.

NATURE (2020)

Article Biochemistry & Molecular Biology

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient

Daming Zhou et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)

Article Multidisciplinary Sciences

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

Johanna Hansen et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Philip J. M. Brouwer et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Anna Z. Wec et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Structural basis of a shared antibody response to SARS-CoV-2

Meng Yuan et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes

Tal Noy-Porat et al.

NATURE COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

Predicting antibody affinity changes upon mutations by combining multiple predictors

Yoichi Kurumida et al.

SCIENTIFIC REPORTS (2020)

Article Multidisciplinary Sciences

Molecular dynamics-guided discovery of an ago-allosteric modulator for GPR40/FFAR1

Michael Luckmann et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Chemistry, Multidisciplinary

Finding the ΔΔG spot: Are predictors of binding affinity changes upon mutations in protein-protein interactions ready for it?

Cunliang Geng et al.

WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2019)

Article Biochemistry & Molecular Biology

Continuous Automated Model EvaluatiOn (CAMEO) complementing the critical assessment of structure prediction in CASP12

Jurgen Haas et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2018)

Article Biochemistry & Molecular Biology

SWISS-MODEL: homology modelling of protein structures and complexes

Andrew Waterhouse et al.

NUCLEIC ACIDS RESEARCH (2018)

Article Biochemical Research Methods

Estimation of the protein-ligand interaction energy for model building and validation

Daria A. Beshnova et al.

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2017)

Article Biochemistry & Molecular Biology

Protein-protein interactions: scoring schemes and binding affinity

M. Michael Gromiha et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2017)

Article Biochemistry & Molecular Biology

Accelerating drug discovery through tight integration of expert molecular design and predictive scoring

Robert Abel et al.

CURRENT OPINION IN STRUCTURAL BIOLOGY (2017)

Article Chemistry, Multidisciplinary

Efficient Discovery of Potent Anti-HIV Agents Targeting the Tyr181Cys Variant of HIV Reverse Transcriptase

William L. Jorgensen et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2011)

Article Chemistry, Multidisciplinary

AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility

Garrett M. Morris et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)

Review Microbiology

The spike protein of SARS-CoV - a target for vaccine and therapeutic development

Lanying Du et al.

NATURE REVIEWS MICROBIOLOGY (2009)

Article Chemistry, Multidisciplinary

A semiempirical free energy force field with charge-based desolvation

Ruth Huey et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2007)

Review Chemistry, Multidisciplinary

Scalable molecular dynamics with NAMD

JC Phillips et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)